Publications
Detailed Information
Influence of stage discrepancy on outcome in patients treated with radical cystectomy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ku, Ja Hyeon | - |
dc.contributor.author | Moon, Kyung Chul | - |
dc.contributor.author | Kwak, Cheol | - |
dc.contributor.author | Kim, Hyeon Hoe | - |
dc.date.accessioned | 2012-06-28T05:56:48Z | - |
dc.date.available | 2012-06-28T05:56:48Z | - |
dc.date.issued | 2010-10 | - |
dc.identifier.citation | TUMORI; Vol.96 5; 699-703 | ko_KR |
dc.identifier.issn | 0300-8916 | - |
dc.identifier.uri | https://hdl.handle.net/10371/77769 | - |
dc.description.abstract | Aims and background. To evaluate the influence of stage discrepancy on clinical outcome in patients with bladder cancer who have undergone radical cystectomy. Methods and study design. We reviewed the records of 155 patients who had undergone radical cystectomy. Of the 155 patients (128 males, 27 females), 68 had clinical nonmuscle invasive disease and 87 had muscle invasive disease. Follow-up ranged from 1.0 to 162.4 months (median, 34.3). Results. There was no significant difference in overall survival according to clinical T stage (P=0.483). However, the actuarial overall survival rate of the pathological muscle invasive disease group was significantly less than that in the pathological nonmuscle invasive disease group (P <0.001). Multivariate analysis with the Cox regression model revealed that lymphovascular invasion (P = 0.001, relative risk [RR] = 2.463) and pathological T stage (P = 0.003, RR = 3.148) were strongly associated with overall survival. There was no difference in cancer-specific survival according to clinical T stage (P = 0.455). However, cancer-specific survival rate of the pathological muscle invasive disease group was significantly less than that in the pathological nonmuscle invasive disease group (P <0.001). Multivariate Cox proportional hazards model analysis showed that lymphovascular invasion (P = 0.001, RR = 2.545) and pathological T stage (P = 0.002, RR = 3.823) were independent predictors of cancer-specific survival. Conclusions. Our findings indicate that clinical stage determined by transurethral resection is not predictive of clinical outcome after radical cystectomy in patients with bladder cancer. Free full text available at www.tumorionline.it | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | CASA EDITRIICE AMBROSIANA | ko_KR |
dc.subject | bladder neoplasm | ko_KR |
dc.subject | cystectomy | ko_KR |
dc.subject | stage | ko_KR |
dc.subject | survival | ko_KR |
dc.subject | recurrence | ko_KR |
dc.title | Influence of stage discrepancy on outcome in patients treated with radical cystectomy | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 구자현 | - |
dc.contributor.AlternativeAuthor | 문경철 | - |
dc.contributor.AlternativeAuthor | 곽철 | - |
dc.contributor.AlternativeAuthor | 김현회 | - |
dc.citation.journaltitle | TUMORI | - |
dc.description.citedreference | Schwaibold HE, 2006, BJU INT, V97, P1199, DOI 10.1111/j.1464-410X.2006.06144.x | - |
dc.description.citedreference | Divrik T, 2006, J UROLOGY, V175, P1258, DOI 10.1016/S0022-5347(05)00689-0 | - |
dc.description.citedreference | Chang SS, 2003, J UROLOGY, V170, P1085, DOI 10.1097/01.ju.0000086828.26001.ca | - |
dc.description.citedreference | Stein JP, 2003, UROLOGY, V62, P591, DOI 10.1016/S0090-4295(03)00584-3 | - |
dc.description.citedreference | Leissner J, 2003, J UROLOGY, V169, P955, DOI 10.1097/01.ju.0000043639.55877.17 | - |
dc.description.citedreference | Dalbagni G, 2002, UROLOGY, V60, P822 | - |
dc.description.citedreference | Hara S, 2001, JPN J CLIN ONCOL, V31, P399 | - |
dc.description.citedreference | Coblentz TR, 2001, CANCER, V91, P1284 | - |
dc.description.citedreference | Herr HW, 1999, J UROLOGY, V162, P74 | - |
dc.description.citedreference | Reuter VE, 1999, HUM PATHOL, V30, P879 | - |
dc.description.citedreference | Bassi P, 1999, J UROLOGY, V161, P1494 | - |
dc.description.citedreference | Epstein JI, 1998, AM J SURG PATHOL, V22, P1435 | - |
dc.description.citedreference | Platz CE, 1996, MODERN PATHOL, V9, P1035 | - |
dc.description.citedreference | FREEMAN JA, 1995, CANCER, V76, P833 | - |
dc.description.citedreference | SOLOWAY MS, 1994, CANCER, V73, P1926 | - |
dc.description.citedreference | AMLING CL, 1994, J UROLOGY, V151, P31 | - |
dc.description.citedreference | PAULSON DF, 1993, SEMIN UROL, V11, P205 | - |
dc.description.citedreference | KLAN R, 1991, J UROLOGY, V146, P316 | - |
dc.description.citedreference | FOSSA SD, 1985, EUR UROL, V11, P1 | - |
dc.description.citedreference | RICHIE JP, 1975, J UROLOGY, V113, P186 | - |
dc.description.citedreference | COX DR, 1972, J ROY STAT SOC B, V34, P187 | - |
dc.description.citedreference | KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457 | - |
dc.description.tc | 0 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.